![Photo](/media/story/26789/thumbnail-01-cedars.jpg)
News • Neuroimaging
A clearer picture of Multiple Sclerosis
Cedars-Sinai physician-scientists are pioneering imaging techniques and investigating new biomarkers to improve multiple sclerosis (MS) diagnosis and treatment.
Cedars-Sinai physician-scientists are pioneering imaging techniques and investigating new biomarkers to improve multiple sclerosis (MS) diagnosis and treatment.
Hypothalamic neurons in an animal model directly detect variations in bacterial activity and adapt appetite and body temperature accordingly.
Engineers at the Massachusetts Institute of Technology (MIT) have developed a telerobotic system to help surgeons quickly and remotely treat patients experiencing a stroke or aneurysm.
Researchers from Charité – Universitätsmedizin Berlin have shown that massive electrochemical waves in the brain act as a marker announcing an impending ischemic stroke.
Scientists use miniature brain models to understand how a mutated gene affects brain development.
For people with atrial fibrillation, one of our most common cardiac disorders, dementia risk is elevated.
Can mobile phones increase the risk of brain cancer? A new, large study was unable to verify such concerns. However, the researchers say it might still be a good idea to cut back on smartphone time.
Scientists are developing a novel method for treating brain haemorrhages which it is hoped could reduce the risk of brain damage and disability and increase patients’ chances of survival.
A wireless sensor could offer doctors a way to monitor changes in brain chemistry without requiring a second operation to remove the implant.
A brain-computer interface array featuring microneedles affixed to a flexible backing allows arrays of micro-scale needles to conform to the contours of the brain.
A significant number of Covid-19 neurological complications – such as fatigue, headache, and cognitive impairment – are ultimately reversible, according to new research.
A new type of AI companion is being designed to aid memory recollection, boost confidence and combat depression in people living with Alzheimer’s disease and other types of dementia.
A mathematical analysis of data obtained with a MRI approach can identify brain cell damage in people at early stages of Alzheimer's.
Using a novel probe for functional magnetic resonance imaging, researchers have devised a way to monitor individual populations of neurons and reveal how they interact with each other.
Scientists have developed a neutron-based method to study brain slices and gain a better understanding of neurological diseases.
When combined with genetic risk factors, the test was up to 93 percent accurate at identifying people at risk of Alzheimer's dementia.
Young children are more optimistic than adolescents, which stems from not learning enough from bad outcomes.
Pre-transplant chemotherapy facilitates the replacement of the brain's innate immune cells, by other immune cells derived from the transplanted stem cells.
Researchers in Zurich have developed a fluorescent orexin biosensor to observe on of the brain's signaling molecules "live" to gain insights into constant daytime sleepiness (narcolepsy).
Children's National Hospital successfully performed the first-ever high-intensity focused ultrasound surgery on a pediatric patient with neurofibromatosis. This is the youngest patient to undergo HIFU treatment in the world.
Scientists at University College London have developed a novel cancer therapy that uses an MRI scanner to guide a magnetic seed through the brain to heat and destroy tumours.
There has to date been no reliable objective method of diagnosing tinnitus. Now, Swedisch researchers may have found a way to measure changes in the brain associated with constant tinnitus.
Cleveland Clinic has launched a landmark study to better understand why millions of people around the world suffer from brain diseases, with the goal of pinpointing disease biomarkers early, well before clinical symptoms present themselves.
Researchers at the University of Sussex are one step further to developing a blood test capable of diagnosing the most aggressive form of brain tumour.
In both the mice and organoids, cytokines suppressed tumor growth after treatment, and defense cells migrated to the brain region affected by the tumor, alerting the immune system to its existence.